Loading
Element Biosciences
AVITI benchtop sequencer with avidity chemistry, competing on accuracy and cost with mid-throughput Illumina systems.
Overview
Element Biosciences, based in San Diego, makes the AVITI benchtop sequencer, which uses avidity chemistry to compete on accuracy and cost with mid-throughput Illumina systems. AVITI and AVITI24, which runs multiomics on a single instrument, were launched between 2022 and 2024. OnCo links it to new short-read sequencing platforms. Whether a benchtop challenger can win clinical laboratories away from the incumbent when assays are validated on Illumina is the open question. The short-read platforms page carries the wider picture.
Connected
2Similar pages
- CompanyUltima Genomics
Shares New short-read sequencing platforms and the tag supporting.
- CompanyMGI Tech
Shares New short-read sequencing platforms and the tag supporting.
fronts
technologies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
elementbiosciences.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/